Navidea Completes Sale Of North American Rights Of Lymphoseek To Cardinal Health Post author:Sam Post published:March 5, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like On a Roll: Magenta Therapeutics Nabs Another $50 Million, a Drug From Novartis AG and Deal With May 1, 2017 Genentech's Tecentriq Impresses Again in Late-Stage Kidney Cancer Trial February 5, 2018 Bioverativ Appoints Executive Vice President, Research And Development April 9, 2017
On a Roll: Magenta Therapeutics Nabs Another $50 Million, a Drug From Novartis AG and Deal With May 1, 2017